Pentoxifylline/Chitosan Films on Wound Healing: In Vitro/In Vivo Evaluation

This study aimed to develop films of chitosan (CSF) associated with pentoxifylline (PTX) for healing cutaneous wounds. These films were prepared at two concentrations, F1 (2.0 mg/mL) and F2 (4.0 mg/mL), and the interactions between the materials, structural characteristics, in vitro release, and mor...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutics Vol. 15; no. 4; p. 1122
Main Authors: Moreira, Vandiara Martins, Leite, Joandra Maísa da Silva, Medeiros, Kaline de Araújo, Assis, Karoll Moangella Andrade de, Borges, Joyce Cordeiro, Santana, Lucas Matheus Barreto, Moreira, Lívia Maria Coelho de Carvalho, Alves, Larissa Pereira, Oliveira, Tharcia Kiara Beserra de, Silveira, João Walter de Souza da, Silva, Dayanne Tomaz Casimiro da, Damasceno, Bolívar Ponciano Goulart de Lima
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 31-03-2023
MDPI
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study aimed to develop films of chitosan (CSF) associated with pentoxifylline (PTX) for healing cutaneous wounds. These films were prepared at two concentrations, F1 (2.0 mg/mL) and F2 (4.0 mg/mL), and the interactions between the materials, structural characteristics, in vitro release, and morphometric aspects of skin wounds in vivo were evaluated. The formation of the CSF film with acetic acid modifies the polymeric structure, and the PTX demonstrates interaction with the CSF, in a semi-crystalline structure, for all concentrations. The release for all films was proportional to the concentration, with two phases: a fast one of ≤2 h and a slow one of >2 h, releasing 82.72 and 88.46% of the drug after 72 h, being governed by the Fickian diffusion mechanism. The wounds of the mice demonstrate a reduction of up to 60% in the area on day 2 for F2 when compared to CSF, F1, and positive control, and this characteristic of faster healing speed for F2 continues until the ninth day with wound reduction of 85%, 82%, and 90% for CSF, F1, and F2, respectively. Therefore, the combination of CSF and PTX is effective in their formation and incorporation, demonstrating that a higher concentration of PTX accelerates skin-wound reduction.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1999-4923
1999-4923
DOI:10.3390/pharmaceutics15041122